Study: Weight-loss meds like Ozempic might increase food waste
America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...
‘I Lost Over 50 Pounds From Zepbound—Here’s Why I Eventually Stopped Taking It’
When I lost weight on WW, I devoted all of my time to the program and I was successful. It was when life got hard that the food noise returned. So, my doctor and I decided to try Zepbound (tirzepatide ...
Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...
Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, ...
Makers of Weight-Loss Drugs Want Your Employer to Pay for Them
On a spring day this year, the New Jersey State Policemen’s Benevolent Association received three unusual visitors: ...
Health.com4d
Goodbye Injections? What to Know About the Weight Loss Pills on the Horizon
Drug manufacturers are racing to develop an oral version of popular weight loss injectables like Ozempic, and early studies ...
Wall Street awaits Amgen weight-loss drug data expected to move shares
Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...
12 NEWS1d
Even with access to blockbuster obesity drugs, some people don't lose weight
Weight loss typically begins right away and continues as the dosage ... Griffin, who didn't respond well to Wegovy, has ...
More Large U.S. Employer Health Plans Covering Weight-Loss Drugs
A survey by consulting firm Mercer shows that close to half of U.S. companies with more than 500 employees now cover drugs ...
What are your questions about weight loss drugs?
Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...
Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...